Ligand profile
TSL
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: VK055_0891 — beta-lactamase SHV-24
Identifiers
Database identifiers and provenance.
- Ligand ID
TSL- PDB
2a3u- UniProt (this protein)
P0AD64- Target protein
- VK055_0891
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 103.7
- −1 ≤ LogP ≤ 5 -0.26
- MW ≤ 500 Da 235.3
- LogP ≤ 5 -0.26
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 103.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)([C@H](C(=O)O)N/C=C/C=O)[S@@](=O)OCC(C)([C@H](C(=O)O)N/C=C/C=O)[S@@](=O)O
InChI=1S/C8H13NO5S/c1-8(2,15(13)14)6(7(11)12)9-4-3-5-10/h3-6,9H,1-2H3,(H,11,12)(H,13,14)/b4-3+/t6-/m0/s1InChI=1S/C8H13NO5S/c1-8(2,15(13)14)6(7(11)12)9-4-3-5-10/h3-6,9H,1-2H3,(H,11,12)(H,13,14)/b4-3+/t6-/m0/s1
DPHUOYJKDIRKGT-YUDCMIJISA-NDPHUOYJKDIRKGT-YUDCMIJISA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand TSL →
- PDB RCSB structure 2a3u →
- UniProt UniProt P0AD64 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “TSL”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0891.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).